Long-term outcome after Bascom's cleft-lift procedure under tumescent local analgesia for pilonidal sinus disease: a cohort study
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Long-term outcome after Bascom's cleft-lift procedure under tumescent local analgesia for pilonidal sinus disease : a cohort study. / Svarre, Kristina J.; Serup, Camilla M.; Kanstrup, Charlotte T.B.; Kleif, Jakob; Bertelsen, Claus A.
I: Colorectal Disease, Bind 25, Nr. 4, 2023, s. 707-716.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Long-term outcome after Bascom's cleft-lift procedure under tumescent local analgesia for pilonidal sinus disease
T2 - a cohort study
AU - Svarre, Kristina J.
AU - Serup, Camilla M.
AU - Kanstrup, Charlotte T.B.
AU - Kleif, Jakob
AU - Bertelsen, Claus A.
N1 - Publisher Copyright: © 2022 The Authors. Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland.
PY - 2023
Y1 - 2023
N2 - Aim: Bascom's cleft-lift procedure for pilonidal sinus disease under tumescent local analgesia is feasible and well tolerated with favourable short-term outcomes. We aimed to assess the 10-year treatment success rate after cleft-lift under tumescent local analgesia. Method: This was a single-centre cohort study based on prospectively registered perioperative data and survey data with additional data from electronic medical records. The cleft-lift procedure was performed under tumescent local analgesia in a day-surgical setting at a tertiary referral hospital between 1 July 2008 and 31 March 2014. The primary outcome was the 10-year risk treatment success defined as complete wound healing within 180 days of surgery or no recurrence assessed with competing risk analyses. Secondary outcomes were time to complete wound healing, persistent pain and cosmetic satisfaction. Results: Two hundred patients with complex pilonidal sinus disease were included. Indication was incomplete wound healing after pilonidal sinus surgery in 43 (21.5%) patients, recurrence after previous intervention in 78 (39.0%) or moderate to complex sinuses assessed by a consultant surgeon in 79 (39.5%). One hundred and ninety-five patients had complete wound healing within 180 days with a median time of 29 days (interquartile range 16–47). The cumulative risk of 10-year recurrence was 11.3% (95% CI 6.2%–16.4%) with a median follow-up time of 8.5 (1.0–10.7) years. Treatment success was 86.1% (95% CI 80.6%–91.5%). No significant predictors were associated with recurrence, and 90% of patients experienced no persistent pain. Conclusion: Cleft-lift performed under tumescent local analgesia has an acceptable 10-year treatment failure rate, making the method feasible in a day-surgery setting.
AB - Aim: Bascom's cleft-lift procedure for pilonidal sinus disease under tumescent local analgesia is feasible and well tolerated with favourable short-term outcomes. We aimed to assess the 10-year treatment success rate after cleft-lift under tumescent local analgesia. Method: This was a single-centre cohort study based on prospectively registered perioperative data and survey data with additional data from electronic medical records. The cleft-lift procedure was performed under tumescent local analgesia in a day-surgical setting at a tertiary referral hospital between 1 July 2008 and 31 March 2014. The primary outcome was the 10-year risk treatment success defined as complete wound healing within 180 days of surgery or no recurrence assessed with competing risk analyses. Secondary outcomes were time to complete wound healing, persistent pain and cosmetic satisfaction. Results: Two hundred patients with complex pilonidal sinus disease were included. Indication was incomplete wound healing after pilonidal sinus surgery in 43 (21.5%) patients, recurrence after previous intervention in 78 (39.0%) or moderate to complex sinuses assessed by a consultant surgeon in 79 (39.5%). One hundred and ninety-five patients had complete wound healing within 180 days with a median time of 29 days (interquartile range 16–47). The cumulative risk of 10-year recurrence was 11.3% (95% CI 6.2%–16.4%) with a median follow-up time of 8.5 (1.0–10.7) years. Treatment success was 86.1% (95% CI 80.6%–91.5%). No significant predictors were associated with recurrence, and 90% of patients experienced no persistent pain. Conclusion: Cleft-lift performed under tumescent local analgesia has an acceptable 10-year treatment failure rate, making the method feasible in a day-surgery setting.
KW - cleft-lift
KW - incomplete wound healing
KW - local analgesia
KW - pilonidal sinus disease
KW - recurrence
KW - tumescent local analgesia
U2 - 10.1111/codi.16420
DO - 10.1111/codi.16420
M3 - Journal article
C2 - 36401803
AN - SCOPUS:85142875759
VL - 25
SP - 707
EP - 716
JO - Colorectal Disease
JF - Colorectal Disease
SN - 1462-8910
IS - 4
ER -
ID: 340411316